New treatment helps control adrenal gland cortical disease in ferrets with a dissolvable implant.
FORT WORTH, TX—August 10, 2012 – Virbac announces the indexing of SUPRELORIN F Implant, a new, non-surgical treatment for ferrets suffering from adrenal gland cortical disease, delivered via a dissolvable, controlled-release implant.
Published studies have shown that SUPRELORIN F Implant effectively manages the clinical signs of adrenal gland cortical disease in ferrets after implantation and remains effective for up to 1 year.* A return to normalcy was reported at 8 weeks for hair loss, at 6 weeks for vulvar swelling, and at 2 weeks for skin disorders and sexual behavior.* Use of SUPRELORIN F (deslorelin acetate) Implant was also shown to suppress key hormones (estradiol, hydroxyprogesterone, and androstenedione) within the treatment period.* The 4.7-mg dose has been shown to be safe for use in the domestic ferret when combined with clinical monitoring by the veterinarian.*
“We are proud to offer veterinarians an alternative to surgery for the treatment of adrenal gland cortical disease in ferrets,” said Mike O’Bryan, Vice President Diversified Commercial Operations. “Many of the veterinarians that serve this targeted market have expressed a need for such a product. The SUPRELORIN F Implant gives veterinarians and their clients more flexibility when treating this disease and offers effective management of the signs of adrenal gland cortical disease for up to 1 full year with a small, subcutaneous implant.”
Virbac will be offering the SUPRELORIN F Implant for purchase online by licensed veterinarians only. For more information, visit www.VirbacFerretsUSA.com/contact-us and provide your contact information to receive updates on when this product will be available.
SUPRELORIN F Implant is not approved by the FDA. SUPRELORIN F Implant is legally marketed as an FDA Indexed Minor Use/Minor Species (MUMS) product under MIF 900-013. SUPRELORIN F Implant is indicated for the management of adrenal gland cortical disease in the male and female domestic ferret only. Extra-label use is prohibited. This product must not be used in animals intended for use as food for humans or other animals. Do not use in animals intended for breeding. The safe use of this product has not been evaluated in pregnant or lactating ferrets. Do not use this product in ferrets with known hypersensitivity to deslorelin acetate or other synthetic hormones. DO NOT HANDLE THIS PRODUCT IF YOU ARE PREGNANT OR NURSING OR SUSPECT YOU MAY BE PREGNANT. Accidental administration may lead to a disruption of the menstrual cycle. See package insert for complete product information.
Virbac develops, manufactures, and distributes a wide range of products and services intended for the prevention and treatment of common pathologies in companion animals. Virbac, located in Fort Worth, Texas, is a leading companion animal health company offering products in the heartworm, tick and flea, dermatology, antibiotic, endocrinology, senior care, behavior, critical care nutrition, and oral hygiene markets. Virbac products are available to pet owners exclusively through a veterinarian. For more information about Virbac and the company’s products, please visit www.virbacvet.com.
# # #
* For a full listing of all literature considered in the Indexing of SUPRELORIN® F Implant, please visit the FDA’s website and review the FOI Summary at: